News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
856,030 Results
Type
Article (87097)
Company Profile (704)
Press Release (768209)
Multimedia
Podcasts (158)
Webinars (21)
Section
Business (232925)
Career Advice (4136)
Deals (39772)
Drug Delivery (132)
Drug Development (91155)
Employer Resources (200)
FDA (18226)
Job Trends (17378)
News (397065)
Policy (39868)
Tag
Academia (3002)
Academic (2)
Accelerated approval (16)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (126)
Alzheimer's disease (1625)
Antibody-drug conjugate (ADC) (196)
Approvals (18201)
Artificial intelligence (424)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (141)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (418)
Cancer (3334)
Cardiovascular disease (268)
Career advice (3545)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (605)
Cervical cancer (27)
Clinical research (74656)
Collaboration (1203)
Company closure (4)
Compensation (804)
Complete response letters (44)
COVID-19 (2924)
CRISPR (71)
C-suite (432)
Cystic fibrosis (127)
Data (3410)
Decentralized trials (2)
Denatured (57)
Depression (87)
Diabetes (395)
Diagnostics (7018)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (197)
Drug pricing (166)
Drug shortages (36)
Duchenne muscular dystrophy (173)
Earnings (98553)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131809)
Executive appointments (936)
FDA (20322)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1074)
Gene editing (154)
Generative AI (42)
Gene therapy (480)
GLP-1 (974)
Government (5319)
Grass and pollen (7)
Guidances (326)
Healthcare (20922)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (201)
Immuno-oncology (17)
Indications (44)
Infectious disease (3132)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (146)
Interviews (813)
IPO (17911)
IRA (59)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (65)
Layoffs (613)
Leadership (28)
Legal (10141)
Liver cancer (88)
Longevity (12)
Lung cancer (463)
Lymphoma (235)
Machine learning (16)
Management (65)
Manufacturing (508)
MASH (112)
Medical device (14789)
Medtech (14801)
Mergers & acquisitions (22642)
Metabolic disorders (1017)
Multiple sclerosis (108)
NASH (23)
Neurodegenerative disease (168)
Neuropsychiatric disorders (48)
Neuroscience (2456)
NextGen: Class of 2025 (7687)
Non-profit (5094)
Now hiring (53)
Obesity (511)
Opinion (300)
Ovarian cancer (109)
Pain (138)
Pancreatic cancer (139)
Parkinson's disease (209)
Partnered (27)
Patents (361)
Patient recruitment (219)
Peanut (55)
People (65906)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23025)
Phase II (32409)
Phase III (24410)
Pipeline (2293)
Policy (270)
Postmarket research (3554)
Preclinical (10401)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (568)
Real estate (7404)
Recruiting (76)
Regulatory (27472)
Reports (64)
Research institute (2668)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (13)
RSV (62)
Schizophrenia (113)
Series A (179)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4311)
State (2)
Stomach cancer (17)
Supply chain (88)
Tariffs (80)
The Weekly (99)
Vaccines (971)
Venture capital (62)
Weight loss (351)
Women's health (53)
Worklife (20)
Date
Today (92)
Last 7 days (552)
Last 30 days (2768)
Last 365 days (33968)
2025 (21569)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (288)
Arkansas (14)
Asia (50676)
Australia (8902)
California (8451)
Canada (2575)
China (780)
Colorado (362)
Connecticut (379)
Delaware (230)
Europe (116347)
Florida (1266)
Georgia (291)
Hawaii (3)
Idaho (67)
Illinois (770)
India (39)
Indiana (410)
Iowa (19)
Japan (253)
Kansas (120)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1175)
Massachusetts (6417)
Michigan (289)
Minnesota (523)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (95)
New Hampshire (75)
New Jersey (2341)
New Mexico (31)
New York (2323)
North Carolina (1310)
North Dakota (10)
Northern California (3719)
Ohio (270)
Oklahoma (17)
Oregon (49)
Pennsylvania (1795)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (40)
South Dakota (1)
Southern California (3173)
Tennessee (136)
Texas (1319)
United States (31638)
Utah (250)
Virginia (229)
Washington D.C. (81)
Washington State (730)
West Virginia (4)
Wisconsin (89)
There are 856,030 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights
US Food and Drug Administration (FDA) has accepted the company’s Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patients
August 21, 2025
·
10 min read
Press Releases
NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury
August 21, 2025
·
9 min read
Press Releases
Model Medicines Selected to Present Preclinical Proof-of-Concept Data for Broad-Spectrum Antiviral MDL-001 at IDWeek 2025
August 21, 2025
·
1 min read
Press Releases
iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform
August 21, 2025
·
4 min read
Business
Washington’s Life Sciences Scene Moves Beyond Research Roots
Washington has had notable life sciences job growth over the past 10 years, according to a Life Science Washington report. The association’s CEO and a biopharma CEO discuss what makes the state stand out, including its talent pool, AI leadership and entrepreneurship support.
August 21, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Biologics Contract Development Market Size to Surpass 23.01 Bn by 2034 Driven by Outsourcing Oncology and Personalized Medicine Growth
August 21, 2025
·
1 min read
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.
August 21, 2025
·
1 min read
·
Lori Ellis
Regulatory
Stealth’s Flight Path Returns to FDA for Rejected Barth Drug
Stealth BioTherapeutics originally submitted elamipretide for approval in January 2024, only to receive a rejection in May of this year. In addition to accepting the biotech’s resubmission, the FDA has promised to take action on the candidate by Sept. 26.
August 21, 2025
·
1 min read
·
Annalee Armstrong
Layoff Tracker
CSL Cuts Thousands in Major Restructuring
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 21, 2025
·
189 min read
·
BioSpace Editorial Staff
Manufacturing
J&J Adds $2B to US Manufacturing Commitment Amid Trump’s Protracted Tariff Threats
President Donald Trump first threatened pharma tariffs in February and recently said they were imminent. Johnson & Johnson’s new investment adds to a $55 billion pledge made by the company in March.
August 21, 2025
·
2 min read
·
Tristan Manalac
1 of 85,603
Next
